Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Westphal

Showing results (121-130 of 140) with videos related to

Pageof 14
Sort By:
Journal of Medicinal Chemistry|September 3, 2011
Small molecule receptor protein tyrosine phosphatase γ (RPTPγ) ligands that inhibit phosphatase activity via perturbation of the tryptophan-proline-aspartate (WPD) loopSteven Sheriff, Brett R Beno, Weixu Zhai, et al.
Genome Medicine|April 13, 2021
Functional interpretation of ATAD3A variants in neuro-mitochondrial phenotypesZheng Yie Yap, Yo Han Park, Saskia B Wortmann, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 20, 2015
Evidence for Classical Cholinergic Toxicity Associated with Selective Activation of M1 Muscarinic ReceptorsAndrew Alt, Annapurna Pendri, Robert L Bertekap, et al.
Annals of Internal Medicine|December 23, 2024
Impaired Wnt/Planar Cell Polarity Signaling in Yellow Nail SyndromeAlina Kurolap, Chofit Chai Gadot, Orly Eshach Adiv, et al.
European Journal of Pharmacology|April 26, 2017
Effects of BMS-902483, an α7 nicotinic acetylcholine receptor partial agonist, on cognition and sensory gating in relation to receptor occupancy in rodentsRick L Pieschl, Regina Miller, Kelli M Jones, et al.
European Journal of Human Genetics : EJHG|April 2, 2024
De novo variants in GABRA4 are associated with a neurological phenotype including developmental delay, behavioral abnormalities and epilepsySamin A Sajan, Ralph Gradisch, Florian D Vogel, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 26, 2015
Discovery of D1 Dopamine Receptor Positive Allosteric Modulators: Characterization of Pharmacology and Identification of Residues that Regulate Species SelectivityMartin A Lewis, Lisa Hunihan, John Watson, et al.
European Journal of Clinical Nutrition|January 28, 2005
Prevalences of hyperhomocysteinemia, unfavorable cholesterol profile and hypertension in European populationsA de Bree, N M J van der Put, L I Mennen, et al.
Gastroenterology|January 24, 2024
Interleukin 21 Drives a Hypermetabolic State and CD4<sup>+</sup> T-Cell-Associated Pathogenicity in Chronic Intestinal InflammationAdebowale O Bamidele, Shravan K Mishra, Guilherme Piovezani Ramos, et al.
Clinical Genetics|February 23, 2021
De novo variants in neurodevelopmental disorders-experiences from a tertiary care centerTheresa Brunet, Robert Jech, Melanie Brugger, et al.
Pageof 14

Showing results (121-130 of 140) with videos related to

Sort By:
Pageof 14
Journal of Medicinal Chemistry|September 3, 2011
Small molecule receptor protein tyrosine phosphatase γ (RPTPγ) ligands that inhibit phosphatase activity via perturbation of the tryptophan-proline-aspartate (WPD) loopSteven Sheriff, Brett R Beno, Weixu Zhai, et al.
Genome Medicine|April 13, 2021
Functional interpretation of ATAD3A variants in neuro-mitochondrial phenotypesZheng Yie Yap, Yo Han Park, Saskia B Wortmann, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 20, 2015
Evidence for Classical Cholinergic Toxicity Associated with Selective Activation of M1 Muscarinic ReceptorsAndrew Alt, Annapurna Pendri, Robert L Bertekap, et al.
Annals of Internal Medicine|December 23, 2024
Impaired Wnt/Planar Cell Polarity Signaling in Yellow Nail SyndromeAlina Kurolap, Chofit Chai Gadot, Orly Eshach Adiv, et al.
European Journal of Pharmacology|April 26, 2017
Effects of BMS-902483, an α7 nicotinic acetylcholine receptor partial agonist, on cognition and sensory gating in relation to receptor occupancy in rodentsRick L Pieschl, Regina Miller, Kelli M Jones, et al.
European Journal of Human Genetics : EJHG|April 2, 2024
De novo variants in GABRA4 are associated with a neurological phenotype including developmental delay, behavioral abnormalities and epilepsySamin A Sajan, Ralph Gradisch, Florian D Vogel, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 26, 2015
Discovery of D1 Dopamine Receptor Positive Allosteric Modulators: Characterization of Pharmacology and Identification of Residues that Regulate Species SelectivityMartin A Lewis, Lisa Hunihan, John Watson, et al.
European Journal of Clinical Nutrition|January 28, 2005
Prevalences of hyperhomocysteinemia, unfavorable cholesterol profile and hypertension in European populationsA de Bree, N M J van der Put, L I Mennen, et al.
Gastroenterology|January 24, 2024
Interleukin 21 Drives a Hypermetabolic State and CD4<sup>+</sup> T-Cell-Associated Pathogenicity in Chronic Intestinal InflammationAdebowale O Bamidele, Shravan K Mishra, Guilherme Piovezani Ramos, et al.
Clinical Genetics|February 23, 2021
De novo variants in neurodevelopmental disorders-experiences from a tertiary care centerTheresa Brunet, Robert Jech, Melanie Brugger, et al.
Pageof 14